Balaxi Pharmaceuticals Limited

Informe acción NSEI:BALAXI

Capitalización de mercado: ₹4.5b

Salud financiera de hoja de balance de Balaxi Pharmaceuticals

Salud financiera controles de criterios 5/6

Balaxi Pharmaceuticals tiene un patrimonio de accionistas total de ₹2.0B y una deuda total de ₹194.0M, lo que sitúa su ratio deuda-patrimonio en 9.6%. Sus activos y pasivos totales son ₹2.6B y ₹569.8M respectivamente. El BAIT de Balaxi Pharmaceuticals es de ₹456.8M, por lo que su ratio de cobertura de intereses es de 26. Tiene efectivo e inversiones a corto plazo que ascienden a ₹625.7M.

Información clave

9.6%

Ratio deuda-patrimonio

₹194.04m

Deuda

Ratio de cobertura de intereses26x
Efectivo₹625.72m
Patrimonio₹2.01b
Total pasivo₹569.79m
Activos totales₹2.58b

Actualizaciones recientes sobre salud financiera

Recent updates

These 4 Measures Indicate That Balaxi Pharmaceuticals (NSE:BALAXI) Is Using Debt Reasonably Well

Jul 30
These 4 Measures Indicate That Balaxi Pharmaceuticals (NSE:BALAXI) Is Using Debt Reasonably Well

Balaxi Pharmaceuticals Limited's (NSE:BALAXI) Share Price Could Signal Some Risk

May 29
Balaxi Pharmaceuticals Limited's (NSE:BALAXI) Share Price Could Signal Some Risk

Market Might Still Lack Some Conviction On Balaxi Pharmaceuticals Limited (NSE:BALAXI) Even After 38% Share Price Boost

Feb 10
Market Might Still Lack Some Conviction On Balaxi Pharmaceuticals Limited (NSE:BALAXI) Even After 38% Share Price Boost

Balaxi Pharmaceuticals (NSE:BALAXI) Has A Pretty Healthy Balance Sheet

Feb 09
Balaxi Pharmaceuticals (NSE:BALAXI) Has A Pretty Healthy Balance Sheet

Is Balaxi Pharmaceuticals (NSE:BALAXI) A Risky Investment?

Aug 08
Is Balaxi Pharmaceuticals (NSE:BALAXI) A Risky Investment?

The Trend Of High Returns At Balaxi Pharmaceuticals (NSE:BALAXI) Has Us Very Interested

May 20
The Trend Of High Returns At Balaxi Pharmaceuticals (NSE:BALAXI) Has Us Very Interested

A Look At The Intrinsic Value Of Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Feb 03
A Look At The Intrinsic Value Of Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Calculating The Intrinsic Value Of Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Sep 06
Calculating The Intrinsic Value Of Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Balaxi Pharmaceuticals (NSE:BALAXI) Knows How To Allocate Capital Effectively

Jun 03
Balaxi Pharmaceuticals (NSE:BALAXI) Knows How To Allocate Capital Effectively

Is Weakness In Balaxi Pharmaceuticals Limited (NSE:BALAXI) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Mar 12
Is Weakness In Balaxi Pharmaceuticals Limited (NSE:BALAXI) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Is Balaxi Pharmaceuticals Limited's(NSE:BALAXI) Recent Stock Performance Tethered To Its Strong Fundamentals?

Nov 27
Is Balaxi Pharmaceuticals Limited's(NSE:BALAXI) Recent Stock Performance Tethered To Its Strong Fundamentals?

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (₹2.1B) de BALAXI superan a sus pasivos a corto plazo (₹542.0M).

Pasivo a largo plazo: Los activos a corto plazo de BALAXI (₹2.1B) superan a sus pasivos a largo plazo (₹27.8M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: BALAXI tiene más efectivo que su deuda total.

Reducción de la deuda: El ratio deuda-patrimonio de BALAXI ha crecido de 0% a 9.6% en los últimos 5 años.

Cobertura de la deuda: La deuda de BALAXI está bien cubierta por el flujo de caja operativo (25.1%).

Cobertura de intereses: Los pagos de intereses de la deuda de BALAXI están bien cubiertos por el BAIT (26x cobertura).


Hoja de balance


Descubre empresas con salud financiera